Clinical Trial

Real-World Mapping Antithrombotic Regimens in MM Patients on Treatment

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to learn about antithrombotic regimens in Multiple myeloma patients. The main question it aims to answer is the efficacy of different types of thromboprophylaxis (antiplatelet agents, heparins, oral anticoagulants) in preventing venous thromboembolism (VTE).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-08-31.
Status change: Not Yet Recruiting → Recruiting 2025-03-12
Trial Details
NCT Number NCT06028087
Lead Sponsor Gruppo Italiano Malattie EMatologiche dell'Adulto
Conditions Multiple Myeloma, Diagnosis
Enrollment 736 participants
Start Date 2025-03-10
Primary Completion 2030-03 (estimated)
Study Completion 2030-03 (estimated)
Updated on ClinicalTrials.gov 2025-03-14